Applied Health Economics and Health Policy

3.0(top 20%)

impact factor

1.0K(top 20%)

papers

17.4K(top 10%)

citations

55(top 10%)

h-index

3.5(top 10%)

impact factor

1.2K

all documents

19.0K

doc citations

87(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	EQ-5D and the EuroQol Group: Past, Present and Future	Applied Health Economics and Health Policy	2017	684
2	Using discrete choice experiments to value health care programmes: current practice and future research reflections	Applied Health Economics and Health Policy	2003	411
3	The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis	Applied Health Economics and Health Policy	2020	345
4	Opportunities for Use of Blockchain Technology in Medicine	Applied Health Economics and Health Policy	2018	220
5	COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa	Applied Health Economics and Health Policy	2020	197
6	To Retain or Remove User Fees?	Applied Health Economics and Health Policy	2006	188
7	Assessing the Performance of a New Generic Measure of Health-Related Quality of Life for Children and Refining it for Use in Health State Valuation	Applied Health Economics and Health Policy	2011	176
8	Patient Preferences Versus Physicians’ Judgement: Does it Make a Difference in Healthcare Decision Making?	Applied Health Economics and Health Policy	2013	162
9	A Pilot Discrete Choice Experiment to Explore Preferences for EQ-5D-5L Health States	Applied Health Economics and Health Policy	2013	147
10	Should Patients Have a Greater Role in Valuing Health States?	Applied Health Economics and Health Policy	2005	139
11	Early Assessment of Medical Technologies to Inform Product Development and Market Access	Applied Health Economics and Health Policy	2011	136
12	Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics	Applied Health Economics and Health Policy	2003	135
13	Screen Time and Health Indicators Among Children and Youth: Current Evidence, Limitations and Future Directions	Applied Health Economics and Health Policy	2017	126
14	Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice	Applied Health Economics and Health Policy	2016	123
15	Costs to Hospitals of Acquiring and Processing Blood in the US	Applied Health Economics and Health Policy	2011	121
16	Medicare Fee-for-Service Enrollees with Primary Acute Myeloid Leukemia: An Analysis of Treatment Patterns, Survival, and Healthcare Resource Utilization and Costs	Applied Health Economics and Health Policy	2013	121
17	Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review	Applied Health Economics and Health Policy	2018	120
18	A Systematic Review of Cost-of-Illness Studies of Multimorbidity	Applied Health Economics and Health Policy	2018	119
19	Valuing Child Health Utility 9D Health States with a Young Adolescent Sample	Applied Health Economics and Health Policy	2011	111
20	How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries	Applied Health Economics and Health Policy	2017	111
21	Quantifying Benefit–Risk Preferences for Medical Interventions: An Overview of a Growing Empirical Literature	Applied Health Economics and Health Policy	2013	106
22	Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA	Applied Health Economics and Health Policy	2016	100
23	Ongoing pharmaceutical reforms in France	Applied Health Economics and Health Policy	2010	97
24	Health-promoting schools	Applied Health Economics and Health Policy	2009	94
25	Comparing Utility Scores Before and After Hearing-Aid Provision	Applied Health Economics and Health Policy	2004	93
26	Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials	Applied Health Economics and Health Policy	2005	87
27	Determinants of Out-of-Pocket Health Expenditure in China	Applied Health Economics and Health Policy	2011	86
28	Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters	Applied Health Economics and Health Policy	2014	86
29	Willingness to Pay for a COVID-19 Vaccine	Applied Health Economics and Health Policy	2021	86
30	US and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review	Applied Health Economics and Health Policy	2015	84
31	Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups	Applied Health Economics and Health Policy	2016	82
32	Soft regulations in pharmaceutical policy making	Applied Health Economics and Health Policy	2009	81
33	Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure	Applied Health Economics and Health Policy	2011	80
34	Resource-Use Measurement Based on Patient Recall: Issues and Challenges for Economic Evaluation	Applied Health Economics and Health Policy	2013	78
35	Impact of Fibromyalgia Severity on Health Economic Costs	Applied Health Economics and Health Policy	2011	76
36	Consumer Mobility in Social Health Insurance Markets	Applied Health Economics and Health Policy	2004	74
37	Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers	Applied Health Economics and Health Policy	2019	73
38	The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data	Applied Health Economics and Health Policy	2021	70
39	Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years	Applied Health Economics and Health Policy	2013	69
40	A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?	Applied Health Economics and Health Policy	2015	67
41	Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US	Applied Health Economics and Health Policy	2013	65
42	Impact of Early Versus Late Systemic Lupus Erythematosus Diagnosis on Clinical and Economic Outcomes	Applied Health Economics and Health Policy	2014	65
43	Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY	Applied Health Economics and Health Policy	2015	65
44	Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis	Applied Health Economics and Health Policy	2017	64
45	Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review	Applied Health Economics and Health Policy	2017	64
46	A Systematic Review of the State of Economic Evaluation for Health Care in India	Applied Health Economics and Health Policy	2015	63
47	An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values	Applied Health Economics and Health Policy	2019	63
48	Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia	Applied Health Economics and Health Policy	2008	62
49	Economic Burden of Non-Cystic Fibrosis Bronchiectasis in the First Year after Diagnosis from A US Health Plan Perspective	Applied Health Economics and Health Policy	2013	62
50	Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19	Applied Health Economics and Health Policy	2020	61

Scientometrics

Overviews

Citing Bodies

Applied Health Economics and Health Policy

Top Articles